Janney Montgomery Scott LLC decreased its position in shares of ARK Genomic Revolution Multi-Sector ETF (NYSEARCA:ARKG – Get Rating) by 32.7% during the third quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 12,729 shares of the company’s stock after selling 6,189 shares during the quarter. Janney Montgomery Scott LLC’s holdings in ARK Genomic Revolution Multi-Sector ETF were worth $418,000 as of its most recent filing with the Securities & Exchange Commission.
Other institutional investors have also recently made changes to their positions in the company. Baird Financial Group Inc. boosted its holdings in ARK Genomic Revolution Multi-Sector ETF by 18.9% in the first quarter. Baird Financial Group Inc. now owns 42,002 shares of the company’s stock worth $1,929,000 after purchasing an additional 6,677 shares during the last quarter. High Net Worth Advisory Group LLC boosted its holdings in ARK Genomic Revolution Multi-Sector ETF by 80.9% in the first quarter. High Net Worth Advisory Group LLC now owns 1,118 shares of the company’s stock worth $51,000 after purchasing an additional 500 shares during the last quarter. Ancora Advisors LLC boosted its holdings in ARK Genomic Revolution Multi-Sector ETF by 35.8% in the first quarter. Ancora Advisors LLC now owns 16,842 shares of the company’s stock worth $1,494,000 after purchasing an additional 4,437 shares during the last quarter. Certified Advisory Corp boosted its holdings in ARK Genomic Revolution Multi-Sector ETF by 4.2% in the first quarter. Certified Advisory Corp now owns 8,675 shares of the company’s stock worth $398,000 after purchasing an additional 353 shares during the last quarter. Finally, Equitable Trust Co. purchased a new stake in ARK Genomic Revolution Multi-Sector ETF in the second quarter worth approximately $1,663,000.
ARK Genomic Revolution Multi-Sector ETF Stock Performance
Shares of ARKG stock opened at $33.36 on Tuesday. ARK Genomic Revolution Multi-Sector ETF has a 12-month low of $26.38 and a 12-month high of $52.47. The firm’s 50 day moving average is $30.75 and its 200 day moving average is $33.78.
See Also
- Get a free copy of the StockNews.com research report on ARK Genomic Revolution Multi-Sector ETF (ARKG)
- Is the Northrop Grumman Selloff an Opportunity?
- Is the Worst Behind for Under Armor Stock with a New CEO?
- What Does Microsoft’s Investment in ChatGBT Mean for MSFT Stock?
- Analysts Like The Fit Of Skechers USA
- Can We Trust The Rally In The S&P 500
Want to see what other hedge funds are holding ARKG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for ARK Genomic Revolution Multi-Sector ETF (NYSEARCA:ARKG – Get Rating).
Receive News & Ratings for ARK Genomic Revolution Multi-Sector ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ARK Genomic Revolution Multi-Sector ETF and related companies with MarketBeat.com's FREE daily email newsletter.